Source: http://www.legis.state.wv.us/WVCODE/code.cfm?chap=60A&art=9&section=1
Timestamp: 2016-09-26 07:42:47
Document Index: 92550295

Matched Legal Cases: ['§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60', '§60']

Chapter 60 A Entire Code ‹ Chapter 60
Chapter 60A | Article 60A - 9
5 - ENFORCEMENT AND ADMINISTRATIVE 6 - MISCELLANEOUS PROVISIONS
60 A- 9 - 1 60 A- 9 - 2 60 A- 9 - 3 60 A- 9 - 4 60 A- 9 - 4 60 A- 9 - 4 A 60 A- 9 - 5 60 A- 9 - 5 60 A- 9 - 5 A 60 A- 9 - 5 A 60 A- 9 - 6 60 A- 9 - 7 60 A- 9 - 7 60 A- 9 - 8 60 A- 9 - 8 10 - METHAMPHETAMINE LABORATORY ER
WVC 60A- CHAPTER 60A. UNIFORM CONTROLLED SUBSTANCES ACT.
WVC 60A-9- ARTICLE 9. CONTROLLED SUBSTANCES MONITORING.
WVC 60 A- 9 - 1 §60A-9-1. Short title.
This article shall be referred to as the West Virginia
Controlled Substances Monitoring Act.
WVC 60 A- 9 - 2 §60A-9-2. Establishment of program; purpose.
There is hereby established a West Virginia controlled
substances monitoring act the purpose of which is to require the
recordation and retention in a single repository of information
regarding the prescribing, dispensing and consumption of certain
WVC 60 A- 9 - 3 §60A-9-3. Reporting system requirements; implementation; central
repository requirement.
(a) The Board of Pharmacy shall implement a program wherein a
central repository is established and maintained which shall
contain such information as is required by the provisions of this
article regarding Schedule II, III, and IV controlled substance
prescriptions written or filled in this state. In implementing
this program, the Board of Pharmacy shall consult with the West
Virginia State Police, the licensing boards of practitioners
affected by this article and affected practitioners.
(b) The program authorized by subsection (a) of this section
shall be designed to minimize inconvenience to patients,
prescribing practitioners and pharmacists while effectuating the
collection and storage of the required information. The board
shall allow reporting of the required information by electronic
data transfer where feasible, and where not feasible, on reporting
forms promulgated by the board. The information required to be
submitted by the provisions of this article shall be required to be
filed no more frequently than within twenty-four hours.
(c) (1) The board shall provide for the electronic
transmission of the information required to be provided by this
article by and through the use of a toll-free telephone line.
(2) A dispenser, who does not have an automated record-keeping
system capable of producing an electronic report in the established
format may request a waiver from electronic reporting. The request for a waiver shall be made to the board in writing and shall be
granted if the dispenser agrees in writing to report the data by
submitting a completed "Pharmacy Universal Claim Form" as defined
by legislative rule.
WVC 60A-9-4
§60A‑9‑4. Required information. (a) Whenever a medical services provider dispenses a controlled substance listed in Schedule II, III or IV as established under the provisions of article two of this chapter or an opioid antagonist, or whenever a prescription for the controlled substance or opioid antagonist is filled by: (i) A pharmacist or pharmacy in this state; (ii) a hospital, or other health care facility, for out‑patient use; or (iii) a pharmacy or pharmacist licensed by the Board of Pharmacy, but situated outside this state for delivery to a person residing in this state, the medical services provider, health care facility, pharmacist or pharmacy shall, in a manner prescribed by rules promulgated by the board under this article, report the following information, as applicable: (1) The name, address, pharmacy prescription number and Drug Enforcement Administration controlled substance registration number of the dispensing pharmacy or the dispensing physician or dentist; (2) The full legal name, address and birth date of the person for whom the prescription is written; (3) The name, address and Drug Enforcement Administration controlled substances registration number of the practitioner writing the prescription; (4) The name and national drug code number of the Schedule II, III and IV controlled substance or opioid antagonist dispensed; (5) The quantity and dosage of the Schedule II, III and IV controlled substance or opioid antagonist dispensed; (6) The date the prescription was written and the date filled; (7) The number of refills, if any, authorized by the prescription; (8) If the prescription being dispensed is being picked up by someone other than the patient on behalf of the patient, the first name, last name and middle initial, address and birth date of the person picking up the prescription as set forth on the person's government‑issued photo identification card shall be retained in either print or electronic form until such time as otherwise directed by rule promulgated by the board; and (9) The source of payment for the controlled substance dispensed. (b) The board may prescribe by rule promulgated under this article the form to be used in prescribing a Schedule II, III, and IV substance or opioid antagonist if, in the determination of the board, the administration of the requirements of this section would be facilitated. (c) Products regulated by the provisions of article ten of this chapter shall be subject to reporting pursuant to the provisions of this article to the extent set forth in said article. (d) Reporting required by this section is not required for a drug administered directly to a patient by a practitioner. Reporting is, however, required by this section for a drug dispensed to a patient by a practitioner: Provided, That the quantity dispensed by a prescribing practitioner to his or her own patient may not exceed an amount adequate to treat the patient for a maximum of seventy‑two hours with no greater than two seventy‑two‑hour cycles dispensed in any fifteen‑day period of time. (e) The Board of Pharmacy shall notify a physician prescribing buprenorphine or buprenorphine/naloxone within sixty days of the availability of the an abuse deterrent form of buprenorphine or buprenorphine/naloxone is approved by the Food and Drug Administration as provided in FDA Guidance to Industry. Upon receipt of the notice, a physician may switch their patients using buprenorphine or buprenorphine/naloxone to the abuse deterrent form of the drug. WVC 60 A- 9 - 4 §60A-9-4. Required information.
(a) Whenever a medical services provider dispenses a
controlled substance listed in Schedule II, III or IV as
established under the provisions of article two of this chapter or
whenever a prescription for the controlled substance is filled by:
(i) A pharmacist or pharmacy in this state; (ii) a hospital, or
other health care facility, for out-patient use; or (iii) a
pharmacy or pharmacist licensed by the Board of Pharmacy, but
situated outside this state for delivery to a person residing in
this state, the medical services provider, health care facility,
pharmacist or pharmacy shall, in a manner prescribed by rules
promulgated by the board under this article, report the following
information, as applicable:
(1) The name, address, pharmacy prescription number and Drug
Enforcement Administration controlled substance registration number
of the dispensing pharmacy or the dispensing physician or dentist;
(2) The full legal name, address and birth date of the person
for whom the prescription is written;
(3) The name, address and Drug Enforcement Administration
controlled substances registration number of the practitioner
writing the prescription;
(4) The name and national drug code number of the Schedule II,
III, and IV controlled substance dispensed;
(5) The quantity and dosage of the Schedule II, III, and IV
controlled substance dispensed;
(7) The number of refills, if any, authorized by the
(8) If the prescription being dispensed is being picked up by
someone other than the patient on behalf of the patient, the first
name, last name and middle initial, address and birth date of the
person picking up the prescription as set forth on the person's
government-issued photo identification card shall be retained in
either print or electronic form until such time as otherwise
directed by rule promulgated by the board; and
(9) The source of payment for the controlled substance
(b) The board may prescribe by rule promulgated under this
article the form to be used in prescribing a Schedule II, III, and
IV substance if, in the determination of the board, the
administration of the requirements of this section would be
(c) Products regulated by the provisions of article ten of
this chapter shall be subject to reporting pursuant to the
provisions of this article to the extent set forth in said article.
(d) Reporting required by this section is not required for a
drug administered directly to a patient by a practitioner. Reporting is, however, required by this section for a drug
dispensed to a patient by a practitioner: Provided, That the
quantity dispensed may not exceed an amount adequate to treat the patient for a maximum of seventy-two hours with no greater than two
seventy-two-hour cycles dispensed in any fifteen-day period of
WVC 60 A- 9 - 4 A
Prior to releasing a Schedule II, III, or IV controlled
substance sold at retail, a pharmacist or pharmacy shall verify the
full legal name, address and birth date of the person picking up
the controlled substance dispensed by requiring the presentation of
a valid government-issued photo identification card. This
information shall be reported in accordance with the provisions of
WVC 60A-9-5
§60A‑9‑5. Confidentiality; limited access to records; period of retention; no civil liability for required reporting. (a)(1) The information required by this article to be kept by the board is confidential and not subject to the provisions of chapter twenty‑nine‑b of this code or obtainable as discovery in civil matters absent a court order and is open to inspection only by inspectors and agents of the board, members of the West Virginia State Police expressly authorized by the Superintendent of the West Virginia State Police to have access to the information, authorized agents of local law‑enforcement agencies as members of a federally affiliated drug task force, authorized agents of the federal Drug Enforcement Administration, duly authorized agents of the Bureau for Medical Services, duly authorized agents of the Office of the Chief Medical Examiner for use in post‑mortem examinations, duly authorized agents of licensing boards of practitioners in this state and other states authorized to prescribe Schedules II, III and IV controlled substances, prescribing practitioners and pharmacists and persons with an enforceable court order or regulatory agency administrative subpoena: Provided, That all law‑enforcement personnel who have access to the Controlled Substances Monitoring Program database shall be granted access in accordance with applicable state laws and the board's legislative rules, shall be certified as a West Virginia law‑enforcement officer and shall have successfully completed training approved by the board. All information released by the board must be related to a specific patient or a specific individual or entity under investigation by any of the above parties except that practitioners who prescribe or dispense controlled substances may request specific data related to their Drug Enforcement Administration controlled substance registration number or for the purpose of providing treatment to a patient: Provided, however, That the West Virginia Controlled Substances Monitoring Program Database Review Committee established in subsection (b) of this section is authorized to query the database to comply with said subsection. (2) Subject to the provisions of subdivision (1) of this subsection, the board shall also review the West Virginia Controlled Substance Monitoring Program database and issue reports that identify abnormal or unusual practices of patients who exceed parameters as determined by the advisory committee established in this section. The board shall communicate with practitioners and dispensers to more effectively manage the medications of their patients in the manner recommended by the advisory committee. All other reports produced by the board shall be kept confidential. The board shall maintain the information required by this article for a period of not less than five years. Notwithstanding any other provisions of this code to the contrary, data obtained under the provisions of this article may be used for compilation of educational, scholarly or statistical purposes, and may be shared with the West Virginia Department of Health and Human Resources for those purposes, as long as the identities of persons or entities and any personally identifiable information, including protected health information, contained therein shall be redacted, scrubbed or otherwise irreversibly destroyed in a manner that will preserve the confidential nature of the information. No individual or entity required to report under section four of this article may be subject to a claim for civil damages or other civil relief for the reporting of information to the board as required under and in accordance with the provisions of this article. (3) The board shall establish an advisory committee to develop, implement and recommend parameters to be used in identifying abnormal or unusual usage patterns of patients in this state. This advisory committee shall: (A) Consist of the following members: A physician licensed by the West Virginia Board of Medicine, a dentist licensed by the West Virginia Board of Dental Examiners, a physician licensed by the West Virginia Board of Osteopathic Medicine, a licensed physician certified by the American Board of Pain Medicine, a licensed physician board certified in medical oncology recommended by the West Virginia State Medical Association, a licensed physician board certified in palliative care recommended by the West Virginia Center on End of Life Care, a pharmacist licensed by the West Virginia Board of Pharmacy, a licensed physician member of the West Virginia Academy of Family Physicians, an expert in drug diversion and such other members as determined by the board. (B) Recommend parameters to identify abnormal or unusual usage patterns of controlled substances for patients in order to prepare reports as requested in accordance with subsection (a), subdivision (2) of this section. (C) Make recommendations for training, research and other areas that are determined by the committee to have the potential to reduce inappropriate use of prescription drugs in this state, including, but not limited to, studying issues related to diversion of controlled substances used for the management of opioid addiction. (D) Monitor the ability of medical services providers, health care facilities, pharmacists and pharmacies to meet the twenty‑four hour reporting requirement for the Controlled Substances Monitoring Program set forth in section three of this article, and report on the feasibility of requiring real‑time reporting. (E) Establish outreach programs with local law enforcement to provide education to local law enforcement on the requirements and use of the Controlled Substances Monitoring Program database established in this article. (b) The board shall create a West Virginia Controlled Substances Monitoring Program Database Review Committee of individuals consisting of two prosecuting attorneys from West Virginia counties, two physicians with specialties which require extensive use of controlled substances and a pharmacist who is trained in the use and abuse of controlled substances. The review committee may determine that an additional physician who is an expert in the field under investigation be added to the team when the facts of a case indicate that the additional expertise is required. The review committee, working independently, may query the database based on parameters established by the advisory committee. The review committee may make determinations on a case‑by‑case basis on specific unusual prescribing or dispensing patterns indicated by outliers in the system or abnormal or unusual usage patterns of controlled substances by patients which the review committee has reasonable cause to believe necessitates further action by law enforcement or the licensing board having jurisdiction over the practitioners or dispensers under consideration. The review committee shall also review notices provided by the chief medical examiner pursuant to subsection (h), section ten, article twelve, chapter sixty‑one of this code and determine on a case‑by‑case basis whether a practitioner who prescribed or dispensed a controlled substance resulting in or contributing to the drug overdose may have breached professional or occupational standards or committed a criminal act when prescribing the controlled substance at issue to the decedent. Only in those cases in which there is reasonable cause to believe a breach of professional or occupational standards or a criminal act may have occurred, the review committee shall notify the appropriate professional licensing agency having jurisdiction over the applicable practitioner or dispenser and appropriate law‑enforcement agencies and provide pertinent information from the database for their consideration. The number of cases identified shall be determined by the review committee based on a number that can be adequately reviewed by the review committee. The information obtained and developed may not be shared except as provided in this article and is not subject to the provisions of chapter twenty‑nine‑b of this code or obtainable as discovering in civil matters absent a court order. (c) The board is responsible for establishing and providing administrative support for the advisory committee and the West Virginia Controlled Substances Monitoring Program Database Review Committee. The advisory committee and the review committee shall elect a chair by majority vote. Members of the advisory committee and the review committee may not be compensated in their capacity as members but shall be reimbursed for reasonable expenses incurred in the performance of their duties. (d) The board shall promulgate rules with advice and consent of the advisory committee, in accordance with the provisions of article three, chapter twenty‑nine‑a of this code. The legislative rules must include, but shall not be limited to, the following matters: (1) Identifying parameters used in identifying abnormal or unusual prescribing or dispensing patterns; (2) Processing parameters and developing reports of abnormal or unusual prescribing or dispensing patterns for patients, practitioners and dispensers; (3) Establishing the information to be contained in reports and the process by which the reports will be generated and disseminated; and (4) Setting up processes and procedures to ensure that the privacy, confidentiality, and security of information collected, recorded, transmitted and maintained by the review committee is not disclosed except as provided in this section. (e) Persons or entities with access to the West Virginia Controlled Substances Monitoring Program database pursuant to this section may, pursuant to rules promulgated by the board, delegate appropriate personnel to have access to said database. (f) Good faith reliance by a practitioner on information contained in the West Virginia Controlled Substances Monitoring Program database in prescribing or dispensing or refusing or declining to prescribe or dispense a schedule II, III, or IV controlled substance shall constitute an absolute defense in any civil or criminal action brought due to prescribing or dispensing or refusing or declining to prescribe or dispense. (g) A prescribing or dispensing practitioner may notify law enforcement of a patient who, in the prescribing or dispensing practitioner's judgment, may be in violation of section four hundred ten, article four of this chapter, based on information obtained and reviewed from the controlled substances monitoring database. A prescribing or dispensing practitioner who makes a notification pursuant to this subsection is immune from any civil, administrative or criminal liability that otherwise might be incurred or imposed because of the notification if the notification is made in good faith. (h) Nothing in the article may be construed to require a practitioner to access the West Virginia Controlled Substances Monitoring Program database except as provided in section five‑a of this article. (i) The board shall provide an annual report on the West Virginia Controlled Substance Monitoring Program to the Legislative Oversight Commission on Health and Human Resources Accountability with recommendations for needed legislation no later than January 1 of each year. WVC 60 A- 9 - 5 §60A-9-5. Confidentiality; limited access to records; period of
retention; no civil liability for required reporting.
(a) (1) The information required by this article to be kept by
the board is confidential and not subject to the provisions of
chapter twenty-nine-b of this code or obtainable as discovery in
civil matters absent a court order and is open to inspection only
by inspectors and agents of the board, members of the West Virginia
State Police expressly authorized by the Superintendent of the West
Virginia State Police to have access to the information, authorized
agents of local law-enforcement agencies as members of a federally
affiliated drug task force, authorized agents of the federal Drug
Enforcement Administration, duly authorized agents of the Bureau
for Medical Services, duly authorized agents of the Office of the
Chief Medical Examiner for use in post-mortem examinations, duly
authorized agents of licensing boards of practitioners in this
state and other states authorized to prescribe Schedules II, III,
and IV controlled substances, prescribing practitioners and
pharmacists and persons with an enforceable court order or
regulatory agency administrative subpoena: Provided, That all
law-enforcement personnel who have access to the Controlled
Substances Monitoring Program database shall be granted access in
accordance with applicable state laws and the board's legislative
rules, shall be certified as a West Virginia law-enforcement
officer and shall have successfully completed training approved by
the board. All information released by the board must be related to a specific patient or a specific individual or entity under
investigation by any of the above parties except that practitioners
who prescribe or dispense controlled substances may request
specific data related to their Drug Enforcement Administration
controlled substance registration number or for the purpose of
providing treatment to a patient: Provided, however, That the West
Virginia Controlled Substances Monitoring Program Database Review
Committee established in subsection (b) of this section is
authorized to query the database to comply with said subsection.
(2) Subject to the provisions of subdivision (1) of this
subsection, the board shall also review the West Virginia
Controlled Substance Monitoring Program database and issue reports
that identify abnormal or unusual practices of patients who exceed
parameters as determined by the advisory committee established in
this section. The board shall communicate with prescribers and
dispensers to more effectively manage the medications of their
patients in the manner recommended by the advisory committee. All
other reports produced by the board shall be kept confidential. The board shall maintain the information required by this article
for a period of not less than five years. Notwithstanding any
other provisions of this code to the contrary, data obtained under
the provisions of this article may be used for compilation of
educational, scholarly or statistical purposes, and may be shared
with the West Virginia Department of Health and Human Resources for
those purposes, as long as the identities of persons or entities and any personally identifiable information, including protected
health information, contained therein shall be redacted, scrubbed
or otherwise irreversibly destroyed in a manner that will preserve
the confidential nature of the information. No individual or
entity required to report under section four of this article may be
subject to a claim for civil damages or other civil relief for the
reporting of information to the board as required under and in
(3) The board shall establish an advisory committee to
develop, implement and recommend parameters to be used in
identifying abnormal or unusual usage patterns of patients in this
state. This advisory committee shall:
(A) Consist of the following members: A physician licensed by
the West Virginia Board of Medicine, a dentist licensed by the West
Virginia Board of Dental Examiners, a physician licensed by the
West Virginia Board of Osteopathy, a licensed physician certified
by the American Board of Pain Medicine, a licensed physician board
certified in medical oncology recommended by the West Virginia
State Medical Association, a licensed physician board certified in
palliative care recommended by the West Virginia Center on End of
Life Care, a pharmacist licensed by the West Virginia Board of
Pharmacy, a licensed physician member of the West Virginia Academy
of Family Physicians, an expert in drug diversion and such other
members as determined by the board.
(B) Recommend parameters to identify abnormal or unusual usage patterns of controlled substances for patients in order to prepare
reports as requested in accordance with subsection (a), subdivision
(C) Make recommendations for training, research and other
areas that are determined by the committee to have the potential to
reduce inappropriate use of prescription drugs in this state,
including, but not limited to, studying issues related to diversion
of controlled substances used for the management of opioid
(D) Monitor the ability of medical services providers, health
care facilities, pharmacists and pharmacies to meet the twenty-four
hour reporting requirement for the Controlled Substances Monitoring
Program set forth in section three of this article, and report on
the feasibility of requiring real-time reporting.
(E) Establish outreach programs with local law enforcement to
provide education to local law enforcement on the requirements and
use of the Controlled Substances Monitoring Program database
established in this article.
(b) The board shall create a West Virginia Controlled
Substances Monitoring Program Database Review Committee of
individuals consisting of two prosecuting attorneys from West
Virginia counties, two physicians with specialties which require
extensive use of controlled substances and a pharmacist who is
trained in the use and abuse of controlled substances. The review
committee may determine that an additional physician who is an expert in the field under investigation be added to the team when
the facts of a case indicate that the additional expertise is
required. The review committee, working independently, may query
the database based on parameters established by the advisory
committee. The review committee may make determinations on a
case-by-case basis on specific unusual prescribing or dispensing
patterns indicated by outliers in the system or abnormal or unusual
usage patterns of controlled substances by patients which the
review committee has reasonable cause to believe necessitates
further action by law enforcement or the licensing board having
jurisdiction over the prescribers or dispensers under
consideration. The review committee shall also review notices
provided by the chief medical examiner pursuant to subsection (h),
section ten, article twelve, chapter sixty-one of this code and
determine on a case-by-case basis whether a practitioner who
prescribed or dispensed a controlled substance resulting in or
contributing to the drug overdose may have breached professional or
occupational standards or committed a criminal act when prescribing
the controlled substance at issue to the decedent. Only in those
cases in which there is reasonable cause to believe a breach of
professional or occupational standards or a criminal act may have
occurred, the review committee shall notify the appropriate
professional licensing agency having jurisdiction over the
applicable prescriber or dispenser and appropriate law-enforcement
agencies and provide pertinent information from the database for their consideration. The number of cases identified shall be
determined by the review committee based on a number that can be
adequately reviewed by the review committee. The information
obtained and developed may not be shared except as provided in this
article and is not subject to the provisions of chapter
twenty-nine-b of this code or obtainable as discovering in civil
matters absent a court order.
(c) The board is responsible for establishing and providing
administrative support for the advisory committee and the West
Committee. The advisory committee and the review committee shall
elect a chair by majority vote. Members of the advisory committee
and the review committee may not be compensated in their capacity
as members but shall be reimbursed for reasonable expenses incurred
(d) The board shall promulgate rules with advice and consent
of the advisory committee, in accordance with the provisions of
article three, chapter twenty-nine-a of this code. The legislative
rules must include, but shall not be limited to, the following
(1) Identifying parameters used in identifying abnormal or
unusual prescribing or dispensing patterns;
(2) Processing parameters and developing reports of abnormal
or unusual prescribing or dispensing patterns for patients,
practitioners and dispensers;
(3) Establishing the information to be contained in reports
and the process by which the reports will be generated and
disseminated; and
(4) Setting up processes and procedures to ensure that the
privacy, confidentiality, and security of information collected,
recorded, transmitted and maintained by the review committee is not
disclosed except as provided in this section.
(e) All practitioners, as that term is defined in section one
hundred-one, article two of this chapter who prescribe or dispense
schedule II, III, or IV controlled substances shall have online or
other form of electronic access to the West Virginia Controlled
Substances Monitoring Program database;
(f) Persons or entities with access to the West Virginia
Controlled Substances Monitoring Program database pursuant to this
section may, pursuant to rules promulgated by the board, delegate
appropriate personnel to have access to said database;
(g) Good faith reliance by a practitioner on information
contained in the West Virginia Controlled Substances Monitoring
Program database in prescribing or dispensing or refusing or
declining to prescribe or dispense a schedule II, III, or IV
controlled substance shall constitute an absolute defense in any
civil or criminal action brought due to prescribing or dispensing
or refusing or declining to prescribe or dispense; and
(h) A prescribing or dispensing practitioner may notify law
enforcement of a patient who, in the prescribing or dispensing practitioner's judgment, may be in violation of section four
hundred ten, article four of this chapter, based on information
obtained and reviewed from the controlled substances monitoring
database. A prescribing or dispensing practitioner who makes a
notification pursuant to this subsection is immune from any civil,
administrative or criminal liability that otherwise might be
incurred or imposed because of the notification if the notification
is made in good faith.
(i) Nothing in the article may be construed to require a
practitioner to access the West Virginia Controlled Substances
Monitoring Program database except as provided in section five-a of
(j) The board shall provide an annual report on the West
Virginia Controlled Substance Monitoring Program to the Legislative
with recommendations for needed legislation no later than January
WVC 60A-9-5A
§60A‑9‑5a. Practitioner requirements to access database and conduct annual search of the database; required rulemaking. (a) All practitioners, as that term is defined in section one hundred‑one, article two of this chapter who prescribe or dispense Schedule II, III or IV controlled substances shall register with the West Virginia Controlled Substances Monitoring Program and obtain and maintain online or other electronic access to the program database: Provided, That compliance with the provisions of this subsection must be accomplished within thirty days of the practitioner obtaining a new license: Provided, however, That no licensing board may renew a practitioner’s license without proof that the practitioner meet the requirements of this subsection. (b) Upon initially prescribing or dispensing any pain‑relieving controlled substance for a patient and at least annually thereafter should the practitioner or dispenser continue to treat the patient with controlled substances, all persons with prescriptive or dispensing authority and in possession of a valid Drug Enforcement Administration registration identification number and, who are licensed by the Board of Medicine as set forth in article three, chapter thirty of this code, the Board of Registered Professional Nurses as set forth in article seven, chapter thirty of this code, the Board of Dental Examiners as set forth in article four, chapter thirty of this code and the Board of Osteopathic Medicine as set forth in article fourteen, chapter thirty of this code shall access the West Virginia Controlled Substances Monitoring Program database for information regarding specific patients for whom they are providing pain‑relieving controlled substances as part of a course of treatment for chronic, nonmalignant pain but who are not suffering from a terminal illness. The information obtained from accessing the West Virginia Controlled Substances Monitoring Program database for the patient shall be documented in the patient's medical record. A pain‑relieving controlled substance shall be defined as set forth in section one, article three‑a, chapter thirty of this code. (c) The various boards mentioned in subsection (b) of this section above shall promulgate both emergency and legislative rules pursuant to the provisions of article three, chapter twenty‑nine‑a of this code to effectuate the provisions of this section. WVC 60 A- 9 - 5 A
§60A-9-5a. Practitioner requirements to conduct annual search of
the database; required rulemaking.
(a) Upon initially prescribing or dispensing any
pain-relieving controlled substance for a patient and at least
annually thereafter should the prescriber or dispenser continue to
treat the patient with controlled substances, all persons with
prescriptive or dispensing authority and in possession of a valid
Drug Enforcement Administration registration identification number
and, who are licensed by the Board of Medicine as set forth in
article three, chapter thirty of this code, the Board of Registered
Professional Nurses as set forth in article seven, chapter thirty
of this code, the Board of Dental Examiners as set forth in article
four, chapter thirty of this code and the Board of Osteopathy as
set forth in article fourteen, chapter thirty of this code shall
access the West Virginia Controlled Substances Monitoring Program
database for information regarding specific patients for whom they
are providing pain-relieving controlled substances as part of a
course of treatment for chronic, nonmalignant pain but who are not
suffering from a terminal illness. The information obtained from
accessing the West Virginia Controlled Substances Monitoring
Program database for the patient shall be documented in the
patient's medical record. A pain-relieving controlled substance
shall be defined as set forth in section one, article three-a,
(b) The various boards mentioned in subsection (a) above shall
promulgate both emergency and legislative rules pursuant to the
provisions of article three, chapter twenty-nine-a of this code to effectuate the provisions of this section.
WVC 60 A- 9 - 6 §60A-9-6. Promulgation of rules.
The state board of pharmacy shall promulgate legislative rules
to effectuate the purposes of this article in accordance with the
WVC 60A-9-7
§60A‑9‑7. Criminal penalties; and administrative violations. (a) Any person who is required to submit information to the state Board of Pharmacy pursuant to the provisions of this article who fails to do so as directed by the board is guilty of a misdemeanor and, upon conviction thereof, shall be fined not less than $100 nor more than $500. (b) Any person who is required to submit information to the state Board of Pharmacy pursuant to the provisions of this article who knowingly and willfully refuses to submit the information required by this article is guilty of a misdemeanor and, upon conviction thereof, shall be confined in a county or regional jail not more than six months or fined not more than $1,000, or both confined and fined. (c) Any person who is required by the provisions of this article to submit information to the state Board of Pharmacy who knowingly submits thereto information known to that person to be false or fraudulent is guilty of a misdemeanor and, upon conviction thereof, shall be confined in a county or regional jail not more than one year or fined not more than $5,000, or both confined and fined. (d) Any person granted access to the information required by the provisions of this article to be maintained by the state Board of Pharmacy, who shall willfully disclose the information required to be maintained by this article in a manner inconsistent with a legitimate law‑enforcement purpose, a legitimate professional regulatory purpose, the terms of a court order or as otherwise expressly authorized by the provisions of this article is guilty of a misdemeanor and, upon conviction thereof, shall be confined in a county or regional jail for not more than six months or fined not more than $1,000, or both confined and fined. (e) Unauthorized access or use or unauthorized disclosure for reasons unrelated to the purposes of this article of the information in the database is a felony punishable by imprisonment in a state correctional facility for not less than one year nor more than five years or fined not less than $3,000 nor more than $10,000, or both imprisoned or fined. (f) Any practitioner who fails to register with the West Virginia Controlled Substances Monitoring Program and obtain and maintain online or other electronic access to the program database as required in subsection (a), section five-a, article nine of this chapter, shall be subject to an administrative penalty of $1,000 by the licensing board of his or her licensure. All such fines collected pursuant to this subsection shall be remitted by the applicable licensing board to the Fight Substance Abuse Fund created under section eight of this article. The provisions of this subsection shall become effective on July 1, 2016. (g) Any practitioner or dispenser who is required to access the information contained in the West Virginia Controlled Substances Monitoring Program database as set forth in subsection (a), section five‑a of this article and fails to do so as directed by the rules of his or her licensing board shall be subject to such discipline as the licensing board deems appropriate and on or after July 1, 2016, be subject to a $100 administrative penalty per violation by the applicable licensing board. All such fines collected pursuant to this subsection shall be transferred by the applicable licensing board to the Fight Substance Abuse Fund created under section eight of this article. (h) Lack of available internet connectivity is a defense to any action brought pursuant to subsections (d) or (f) of this section. WVC 60 A- 9 - 7 §60A-9-7. Criminal penalties.
(a) Any person who is required to submit information to the
state Board of Pharmacy pursuant to the provisions of this article
who fails to do so as directed by the board is guilty of a
than $100 nor more than $500.
(b) Any person who is required to submit information to the
who knowingly and willfully refuses to submit the information
required by this article is guilty of a misdemeanor and, upon
conviction thereof, shall be confined in a county or regional jail
not more than six months or fined not more than $1,000, or both
confined or fined.
(c) Any person who is required by the provisions of this
article to submit information to the state Board of Pharmacy who
knowingly submits thereto information known to that person to be
false or fraudulent is guilty of a misdemeanor and, upon conviction
thereof, shall be confined in a county or regional jail not more
than one year or fined not more than $5,000, or both confined or
(d) Any prescriber or dispenser who is required to access the
information contained in the West Virginia Controlled Substances
Monitoring Program database as set forth in subsection (a) of
section five-a of this article and fails to do so as directed by
the rules of their licensing board shall be subject to such
discipline as the licensing board deems appropriate.
(e) Any person granted access to the information required by the provisions of this article to be maintained by the state Board
of Pharmacy, who shall willfully disclose the information required
to be maintained by this article in a manner inconsistent with a
legitimate law-enforcement purpose, a legitimate professional
regulatory purpose, the terms of a court order or as otherwise
expressly authorized by the provisions of this article is guilty of
a misdemeanor and, upon conviction thereof, shall be confined in a
county or regional jail for not more than six months or fined not
more than $1,000, or both confined or fined.
(f) Unauthorized access or use or unauthorized disclosure for
reasons unrelated to the purposes of this article of the
information in the database is a felony punishable by imprisonment
in a state correctional facility for not less than one year nor
more than five years or fined not less than $3,000 nor more than
$10,000, or both imprisoned or fined.
WVC 60A-9-8
§60A‑9‑8. Creation of Fight Substance Abuse Fund. There is hereby created a special revenue account in the state treasury, designated the Fight Substance Abuse Fund, which shall be an interest‑bearing account. The fund shall consist of all moneys received from whatever source to further the purpose of this article. The fund shall be administered by the West Virginia Bureau for Public Health to provide funding for substance abuse prevention, treatment, treatment coordination, recovery and education. Any moneys remaining in the fund at the close of a fiscal year shall be carried forward for use in the next fiscal year. Fund balances shall be invested with the state’s consolidated investment fund and any and all interest earnings on these investments shall be used solely for the purposes that moneys deposited in the fund may be used pursuant to this article. There is created within the Office of the Secretary of the Department of Health and Human Resources the Grant Writer Pilot Project. The Secretary shall hire a person as a grant writer, who shall be placed within the Office of the Secretary. This person shall identify, application and monitoring policies and procedures to increase grant applications and improve management and oversight of grants. The grant writer shall focus his or her abilities on obtaining grants concerning the prevention and treatment of substance abuse. The grant writer is not eligible for civil service. The department shall report to the Legislative Oversight Commission on Health and Human Resources Accountability on the implementation of the new grant policy; the number of grants obtained; and an analysis examining the costs associated with obtaining a grant verses the federal money received. WVC 60 A- 9 - 8 §60A-9-8. Creation of Fight Substance Abuse Fund.
treasury, designated the Fight Substance Abuse Fund, which shall be
an interest-bearing account and may be invested in accordance with
the provisions of article six, chapter twelve of this code, with
interest income a proper credit to the fund. The fund shall
consist of appropriations by the Legislature, gifts, donations or
any other source. Expenditures from the fund shall be for the
following purposes: to provide funding for substance abuse
prevention, treatment, treatment coordination, recovery and